Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Immunogenicity and Safety of GSK Biologicals' Tdap Booster Vaccine (Boostrix™) in Young Adults, Administered 10 Years After Previous Tdap Boosting

NCT01738477 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT01738477
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01738477 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Immunogenicity and Safety of GSK Biologicals' Tdap Booster Vaccine (Boostrix™) in Young Adults, Administered 10 Years After Previous Tdap Boosting
Lead sponsor
GlaxoSmithKline
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2013
Completion date
April 2, 2014
Enrollment
165 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

acellular pertussis, diphtheria, tetanus